Zobrazeno 21 - 30
of 189
pro vyhledávání: ''
Autor:
Maria Ponticelli, Laura Hidalgo-García, Patricia Diez-Echave, Teresa Vezza, Miguel Romero, Iñaki Robles-Vera, Juan Duarte, Filomena De Biasio, Domenico Gorgoglione, Ludovica Lela, Julio Galvez, Luigi Milella
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction:Solanum aethiopicum L., commonly known as scarlet eggplant (Solanaceae family) is one of the most traditionally cultivated vegetables in Basilicata, a southern region of Italy. Although multiple uses have been given to this vegetable, da
Externí odkaz:
https://doaj.org/article/f641a4de67664c58beadab756ca8fa62
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/ad0cfcfc4f77417d8981dcc7c05a9c62
Autor:
Kyungha Min, Bumjo Oh, Hye Yeon Koo, Yang-Hyun Kim, Ji-Won Lee, Sangsub Lee, Youngah Kim, Hyuktae Kwon
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Glaceum Inc. has proposed HSG4112, a structural analogue of glabridin, as a novel anti-obesity compound. Animal studies and phase I human trials have shown that HSG4112 improves energy consumption, normalises weight, and is safe and drug-
Externí odkaz:
https://doaj.org/article/88d4e45a96b844b19819f5ef6b404e96
Autor:
Ravishankar Chandrasekaran, Carolyn R. Morris, Isabella M. Butzirus, Zoe F. Mark, Amit Kumar, Dhemerson Souza De Lima, Nirav Daphtary, Minara Aliyeva, Matthew E. Poynter, Vikas Anathy, Anne E. Dixon
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Obesity is a risk factor for severe influenza, and asthma exacerbations caused by respiratory viral infections. We investigated mechanisms that increase the severity of airway disease related to influenza in obesity using cells derived from obese and
Externí odkaz:
https://doaj.org/article/102c1f06ace041a5879ef9e87c8fd3d8
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/a25102a0b8f54a0ba588c519ef32d5b0
Autor:
Nehal M. Ramadan, Priscila O. Barbosa, Nada F. Abo El-Magd, Salma M. Eraky, Mohammed M. H. Al-Gayyar
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/6ec0ae91e23249c59c775e612980dec2
Autor:
Gabriela Reolon Passos, Mariana G. de Oliveira, Ana Carolina Ghezzi, Glaucia C. Mello, Carlos Arturo Levi D’Ancona, Simone Aparecida Teixeira, Marcelo Nicolas Muscará, Carla Beatriz Grespan Bottoli, Lucilia Vilela de Melo, Eliezer de Oliveira, Edson Antunes, Fabiola Zakia Mónica
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: The prostate gland is surrounded by periprostatic adipose tissue (PPAT) that can release mediators that interfere in prostate function. In this study, we examined the effect of periprostatic adipose tissue supernatant obtained from obese
Externí odkaz:
https://doaj.org/article/941acf96e0014e35acb812c923da8315
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Diabetes mellitus is mainly classified into four types according to its pathogenesis, of which type 2 diabetes mellitus (T2DM) has the highest incidence rate and is most relevant to obesity. It is characterized by high blood glucose, which is primari
Externí odkaz:
https://doaj.org/article/a5cbe8d8b44543daa909f7b9b44d1247
Autor:
Ummul Fathima Shaik Mohamed Sayed, Said Moshawih, Hui Poh Goh, Nurolaini Kifli, Gaurav Gupta, Sachin Kumar Singh, Dinesh Kumar Chellappan, Kamal Dua, Andi Hermansyah, Hooi Leng Ser, Long Chiau Ming, Bey Hing Goh
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Obesity affects more than 10% of the adult population globally. Despite the introduction of diverse medications aimed at combating fat accumulation and obesity, a significant number of these pharmaceutical interventions are linked to substantial occu
Externí odkaz:
https://doaj.org/article/a4e4d24bbab544128efd523156c5b940
Autor:
Qiming Ma, Li Wen, Yanxia Tian, Liqin Ma, Zhangsheng Wen, Yang Kun, Mengping Xu, Xiaoping Liu
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: A high-fat Western diet is a risk factor for obesity and steatosis. Reducing intestinal absorption of a high-fat diet (HFD) is a feasible strategy to control obesity. Sulfosuccinimidyl oleate (SSO) inhibits intestinal fatty acid transport
Externí odkaz:
https://doaj.org/article/c0c99753a9314a6baf1f18be6cabcb9b